A Antibiotics Market, By Products (Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Sulfonamides

Antibiotics Market, By Products (Cephalosporins, Penicillins, Fluroquinilones, Macrolides, Carbapenems, Sulfonamides, Aminoglycosides, and Other Products), By Spectrum (Broad-Spectrum Antibiotics and Narrow-Spectrum Antibiotics), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Antibiotics are medicines that fight bacterial infections in people and animals. These drugs help destroy or slow down the growth of bacteria. Antibiotics either kill bacteria or stop them from reproducing, allowing the body to eliminate pathogens. When used properly, antibiotics can save lives. Thus, there is an increase in demand for antibiotics worldwide.

Market Dynamics:

Rising prevalence of bacterial infections, high consumption of antibiotics, need for effective and newer antibiotics, growing geriatric population, and favorable government initiatives are major factors expected to aid in the growth of the global antibiotics market. For instance, in March 2019, Global Antibiotic Research and Development Partnership (GARDP) announced a public-private partnership with Evotec AG for the development of first-in-class antibiotics for treating drug-resistant bacterial infections.

Moreover, in August 2019, the U.S. Food and Drug Administration (FDA) approved Xenleta (lefamulin), a new antibiotic to treat adults with community-acquired bacterial pneumonia. The new antibiotic provides another option for the treatment of patients with community-acquired bacterial pneumonia, a serious disease

Key features of the study:

• This report provides in-depth analysis of the global antibiotics market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global antibiotics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Roche Holding AG, Abbott Laboratories, Sanofi SA, Novartis AG, AstraZeneca, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline, and Bayer Healthcare AG, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibiotics market.

• Global Antibiotics Market By Products:
• Cephalosporins
• Penicillins
• Fluroquinilones
• Macrolides
• Carbapenems
• Sulfonamides
• Aminoglycosides
• Other Products
• Global Antibiotics Market By Spectrum:
• Broad-Spectrum Antibiotics
• Narrow-Spectrum Antibiotics
• Global Antibiotics Market By Geography:
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America
• Company Profiles:
• Roche Holding AG
• Abbott Laboratories
• Sanofi SA
• Novartis AG
• AstraZeneca
• Pfizer Inc.
• Merck & Co. Inc.
• Johnson & Johnson
• GlaxoSmithKline
• Bayer Healthcare AG